A carregar...
Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies
Recurrent and unpredictable episodes of vaso-occlusion are the hallmark of sickle cell disease. Symptomatic management and prevention of these events using the fetal hemoglobin–reactivating agent hydroxyurea are currently the mainstay of treatment. Discoveries over the past 2 decades have highlighte...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3854110/ https://ncbi.nlm.nih.gov/pubmed/24052549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-05-498311 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|